1
|
Ezigbo ED, Enitan SS, Adejumo EN, Durosinmi AE, Akele RY, Dada MO, Itodo GE, Idoko AM, Edafetanure-Ibeh OM, Okafor EN, Abdulsalam AA, Oyedoyin OI, Yelpoji PU, Opeyemi OO, Nmesomachi OS, Oyekale AO, Onyeji CB. Acceptance of COVID-19 vaccine and its related determinants in Nigeria: An online survey. World J Virol 2024; 13:98551. [PMID: 39722760 PMCID: PMC11551692 DOI: 10.5501/wjv.v13.i4.98551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/29/2024] [Revised: 08/14/2024] [Accepted: 09/02/2024] [Indexed: 10/18/2024] Open
Abstract
BACKGROUND Vaccine hesitancy is a major challenge in the fight against the coronavirus disease 2019 (COVID-19) pandemic. Identifying the sociodemographic factors associated with vaccine acceptance among Nigerians is crucial for improving vaccine uptake. AIM To assess the acceptance rate of COVID-19 vaccine and its related determinants among Nigerians. METHODS An online cross-sectional survey (observational study) was conducted between February 2021 and May 2021, using a questionnaire hosted on SurveyMonkey. The invitation to take part in the poll was sent out to participants through social networking platforms. A logistic regression was used to determine which sociodemographic factors were associated with vaccine acceptance constructs. RESULTS A total of 1800 persons responded to the survey, a larger proportion of whom were males (53.9%) and within the age group of 21-30 years (29.4%) and earned an average income of less than $500 per month (43.3%). Only 0.56% of participants had a high perceived risk of COVID-19 infection, while only 1.11% had a perceived risk of dying from COVID-19. The perception rate of the COVID-19 vaccine among participants was 51.1%, while the acceptance rate was 63.9%. There was no significant association between the COVID-19 vaccine acceptance rate and related determinants assessed, particularly age (χ² = 3.049, P = 0.550), sex (χ² = 0.102, P = 0.749), average income (χ² = 3.802, P = 0.875), and religion (χ² = 2.819, P = 0.420). Participants with chronic conditions demonstrated a higher acceptance rate compared to the general population. CONCLUSION Despite the positive perception observed and substantial vaccine acceptance rate among the study participants, more public health interventions are still needed to enhance vaccine acceptability in Nigeria.
Collapse
Affiliation(s)
- Eyiuche D Ezigbo
- Haemostasis and Thrombosis Unit, Department of Medical Laboratory Sciences, University of Nigeria, Enugu Campus, Enugu, EN 400241, Nigeria
| | - Seyi S Enitan
- Department of Medical Laboratory Science, School of Public and Allied Health, Babcock University, Ilishan-Remo, OG 121109, Nigeria
| | - Esther N Adejumo
- Department of Medical Laboratory Science, School of Public and Allied Health, Babcock University, Ilishan-Remo, OG 121109, Nigeria
| | - Abiodun E Durosinmi
- Department of Medical Laboratory Science, State Hospital, Ijebu-Ode, OG 120221, Nigeria
| | - Richard Y Akele
- Department of Biomedical Science, School of Applied Science, University of Brighton, Brighton, ES BN2 4AT, United Kingdom
| | - Michael O Dada
- Department of Medical Laboratory Science, School of Public and Allied Health, Babcock University, Ilishan-Remo, OG 121109, Nigeria
| | - Grace E Itodo
- Department of Microbiology, Federal Teaching Hospital Lokoja, Lokoja, KO 260006, Nigeria
| | - Abah M Idoko
- Department of Hematology and Blood Group Serology, Federal College of Veterinary and Medical Laboratory Technology, Vom, PL 930101, Nigeria
| | - Okeoghene M Edafetanure-Ibeh
- Department of Environmental and Occupational Health, Texas A and M University School of Public Health, Garland, TX 75049, United States
| | - Edwin N Okafor
- Division of Chemical Pathology, Department of Medical Laboratory Sciences, University of Nigeria, Enugu Campus, Enugu, EN 400102, Nigeria
| | - Adedeji A Abdulsalam
- School of Molecular Bioscience Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, SCO G12 8QQ, United Kingdom
| | - Oyekan I Oyedoyin
- Department of Medical Laboratory Science, State Hospital Ijebu-Ode, Ijebu-Ode, OG 360101, Nigeria
| | - Polit U Yelpoji
- Department of Medical Laboratory Science, Faculty of Health Sciences and Technology, University of Jos, Jos, PL 930103, Nigeria
| | - Ogunwola O Opeyemi
- Department of Medical Laboratory Science, Bola Tinubu Health and Diagnostic Center, Lagos, LA 100102, Nigeria
| | - Ogbuji S Nmesomachi
- Department of Pathology, 68 Nigerian Army Reference Hospital, Yaba, LA 1211001, Nigeria
| | - Adesola O Oyekale
- Department of Medical Laboratory Science, Ladoke Akintola University of Technology, Ogbomoso, OS 2111105, Nigeria
| | - Chisom B Onyeji
- Department of Medical Laboratory Science, School of Public and Allied Health, Babcock University, Ilishan-Remo, OG 121109, Nigeria
| |
Collapse
|
2
|
Dinga JN, Kabakama S, Njimoh DL, Chia JE, Morhason-Bello I, Lumu I. Quantitative Synthesis of Factors Associated with COVID-19 Vaccine Acceptance and Vaccine Hesitancy in 185 Countries. Vaccines (Basel) 2023; 12:34. [PMID: 38250847 PMCID: PMC10818751 DOI: 10.3390/vaccines12010034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2023] [Revised: 12/18/2023] [Accepted: 12/26/2023] [Indexed: 01/23/2024] Open
Abstract
Mass vaccination against COVID-19 is the best method to ensure herd immunity in order to curb the effect of the pandemic on the global economy. It is therefore important to assess the determinants of COVID-19 vaccine acceptance and hesitancy on a global scale. Factors were recorded from cross-sectional studies analyzed with t-Test, ANOVA, correlation, and meta-regression analyses and synthesized to identify global trends in order to inform policy. We registered the protocol (ID: CRD42022350418) and used standard Cochrane methods and PRISMA guidelines to collect and synthesize cross-sectional articles published between January 2020 and August 2023. A total of 67 articles with 576 studies from 185 countries involving 3081,766 participants were included in this synthesis. Global COVID-19 vaccine acceptance was 65.27% (95% CI; 62.72-67.84%), while global vaccine hesitancy stood at 32.1% (95% CI; 29.05-35.17%). One-Way ANOVA showed that there was no significant difference in the percentage Gross Domestic Product spent on vaccine procurement across the World Bank income levels (p < 0.187). There was a significant difference of vaccine acceptance (p < 0.001) and vaccine hesitancy (p < 0.005) across the different World Bank Income levels. World Bank income level had a strong influence on COVID-19 vaccine acceptance (p < 0.0004) and hesitancy (p < 0.003) but percentage Gross Domestic Product spent on vaccine procurement did not. There was no correlation between percentage Gross Domestic Product spent on vaccine procurement and COVID-19 vaccine acceptance (r = -0.11, p < 0.164) or vaccine hesitancy (r = -0.09, p < 0.234). Meta-regression analysis showed that living in an urban setting (OR = 4.83, 95% CI; 0.67-212.8), rural setting (OR = 2.53, 95% CI; 0.29-119.33), older (OR = 1.98, 95% CI; 0.99-4.07), higher education (OR = 1.76, 95% CI; 0.85-3.81), and being a low income earner (OR = 2.85, 95% CI; 0.45-30.63) increased the odds of high COVID-19 vaccine acceptance. Factors that increased the odds of high COVID-19 vaccine hesitancy were no influenza vaccine (OR = 33.06, 95% CI; 5.03-1395.01), mistrust for vaccines (OR = 3.91, 95% CI; 1.92-8.24), complacency (OR = 2.86, 95% CI; 1.02-8.83), pregnancy (OR = 2.3, 95% CI; 0.12-141.76), taking traditional herbs (OR = 2.15, 95% CI; 0.52-10.42), being female (OR = 1.53, 95% CI; 0.78-3.01), and safety concerns (OR = 1.29, 95% CI; 0.67-2.51). We proposed a number of recommendations to increase vaccine acceptance and ensure global herd immunity against COVID-19.
Collapse
Affiliation(s)
- Jerome Nyhalah Dinga
- Michael Gahnyam Gbeugvat Foundation, Buea P.O. Box 63, Cameroon
- Biotechnology Unit, University of Buea, Buea P.O. Box 63, Cameroon
| | - Severin Kabakama
- Humanitarian and Public Health Consultant, Mwanza P.O. Box 511, Tanzania
| | - Dieudonne Lemuh Njimoh
- Department of Biochemistry and Molecular Biology, University of Buea, Buea P.O. Box 63, Cameroon
| | - Julius Ebua Chia
- World Health Organization-Regional Office for Africa, Brazaville P.O. Box 06, Congo
| | | | - Ivan Lumu
- Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala P.O. Box 7072, Uganda
| |
Collapse
|